Hysteroscopic "360°" Surgery for Improvement of Symptoms in Cesarean Scar Defects

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorFu Xing Hospital, Capital Medical University

About this trial

Patients with symptomatic Cesarean Scar Defect (CSD) who are expected to undergo hysteroscopic surgery will be randomly divided into the traditional hysteroscopic "channelization" treatment group and the hysteroscopic "360 °" Surgery group of cesarean diverticulum, and the improvement of postoperative clinical symptoms of the two groups will be compared. To evaluate the effectiveness of the two surgical methods.

The purpose of this study was to evaluate the improvement of symptoms of women with symptomatic cesarean diverticulum through a high-quality randomized controlled study, in order to provide high-level evidence-based medical evidence for clinical treatment.

Eligibility criteria

Qualifiers

Patients with surgical adaptation: changes in menstruation after cesarean section (prolonged menstrual period)

No surgical contraindications;

Age 18-45 years old;

The thickness of residual muscle layer measured by ultrasound is greater than or equal to 2.5mm;

Disqualifiers

Patients with other diseases that may cause abnormal uterine bleeding (including endometrial polyps, endometrial hyperplasia, submucosal myoma, etc.) indicated by two-dimensional ultrasound

There are contraindications of surgery: such as severe internal and surgical complications, pregnancy, reproductive tract infection, malignant tumor;

Trial design

Treatments tested in this trial

  • 360°
  • traditional

Treatment groups

88 Participants
are divided into 2 treatment groups

Locations

This trial has no locations